Clinical Trial Update: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in Treated Patients With Chronic Hepatitis B [Phase 2]

View source ↗

Summary

This update reports on a multicenter, randomized, double-blind, placebo-controlled Phase II study of TVAX-008 for chronic hepatitis B. The trial status is activ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• TVAX-008

Snippet

Sponsor: Grand Theravac Life Sciences (Nanjing) Co., Ltd. | Conditions: Chronic Hepatitis B Virus | Phase 2 | Status: ACTIVE_NOT_RECRUITING